Models of cost-effectiveness of recombinant FSH versus urinary FSH.
Al-Inany
H
H
Afnan
M
M
D003362:Cost-Benefit Analysis; D005260:Female; D005307:Fertilization in Vitro / Q000191:economics; D005640:Follicle Stimulating Hormone / Q000191:economics* / Q000627:therapeutic use / Q000652:urine; D006801:Humans; D007247:Infertility, Female / Q000191:economics / Q000628:therapy; D011247:Pregnancy; D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use; D020554:Sperm Injections, Intracytoplasmic / Q000191:economics
D011994:Recombinant Proteins; D005640:Follicle Stimulating Hormone